GANGLIONEUROBLASTOMA

This adverse event was reported 16 times

GANGLIONEUROBLASTOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIGLUSTAT 1 0.0009
1 IFOSFAMIDE FOR INJECTION 7 0.0003
2 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 1 0.0003
3 EMICIZUMAB 2 0.0002
4 ETOPOSIDE 8 0.0001
5 DOXORUBICIN 8 0.0001
6 OXCARBAZEPINE 1 0.0001
7 CLOBAZAM 1 0.0001
8 PHENYTOIN 1 0.0000
9 VINCRISTINE SULFATE 1 0.0000
See all drugs enriched for association with GANGLIONEUROBLASTOMA

GANGLIONEUROBLASTOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Enzyme Stabilizer [EPC] 1 0.0009
1 Glucosylceramide Synthase Inhibitor [EPC] 1 0.0004
2 Topoisomerase Inhibitor [EPC] 8 0.0001
3 Recombinant Human Growth Hormone [EPC] 1 0.0000
4 Alkylating Drug [EPC] 8 0.0000
5 Anti-epileptic Agent [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
7 Benzodiazepine [EPC] 1 0.0000
8 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with GANGLIONEUROBLASTOMA